We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 9 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 5 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 06. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 05. 05. | Guggenheim | — | Initiate coverage | — → Buy | — | Guggenheim: Buy |
| 2026. 04. 30. | Wedbush | — | Maintain | Outperform → Outperform | — | Wedbush: Outperform |
| 2026. 04. 16. | Oppenheimer | — | Initiate coverage | — → Outperform | — | Oppenheimer: Outperform |
| 2026. 03. 31. | Wedbush | — | Maintain | Outperform → Outperform | — | Wedbush: Outperform |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.